MedCity News October 21, 2024
Eve McDavid

Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches.

Investors pour billions of dollars into cancer research and treatment innovation each year. However, pennies on the dollar are directed toward rare cancers and cancers such as cervical cancer that disproportionately affect marginalized communities.

In order for these fields to have sufficiently funded research that yields breakthrough advances, the healthcare industry needs novel funding models to target these fields. This is where the greatest innovation potential exists to close cancer equity gaps.

My interest in this field is personal – In 2020, I survived a deadly stage IIB cervical cancer diagnosis. As a healthcare innovator, I’ve seen the critical need for cervical cancer advancements because...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Provider, Trends
How Crunchbase AI Is Forecasting Unicorns With 95% Accuracy
AI competition is eating the world
Private equity firm to buy Walgreens for $10B, report says
Flosonics Medical Secures C$7.5M to Scale Wearable Ultrasound Tech | StartUp Health Insights: Week of Mar 4, 2025
Bluebird Kids Health Raises $31.5M for Its Value-Based Pediatric Care Clinics in Underserved Areas

Share This Article